# China NMPA Product Recall - Absorbable surgical sutures

Source: https://www.globalkeysolutions.net/records/china_product_recall/jiangxi-kangding-biotechnology-co-ltd/68c8d83e-ee17-444f-8c17-aad7e0e75af2/
Source feed: China

> China NMPA product recall for Absorbable surgical sutures by Jiangxi Kangding Biotechnology Co., Ltd. published July 29, 2019. Recall level: Level 3 Recall. Jiangxi Longteng Biotechnology Co., Ltd. has initiated a voluntary recall of its absorbable surgical

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Jiangxi Longteng Biotechnology Co., Ltd. voluntarily recalls absorbable surgical sutures
- Company Name: Jiangxi Kangding Biotechnology Co., Ltd.
- Publication Date: 2019-07-29
- Product Name: Absorbable surgical sutures
- Recall Level: Level 3 Recall
- Recall Reason: The seal was not tight
- Discovering Company: Jiangxi Longteng Biotechnology Co., Ltd.
- Manufacturing Company: Jiangxi Kangding Biotechnology Co., Ltd.
- Summary: Jiangxi Longteng Biotechnology Co., Ltd. has initiated a voluntary recall of its absorbable surgical sutures, a measure officially reported to the National Medical Products Administration (NMPA). The primary reason for this action is a identified manufacturing defect concerning the sealing integrity of these critical medical devices. The affected absorbable surgical sutures are specifically identified by Registration Certificate No. 20173651022. This recall has been classified as Class III, signifying that while there is a product deficiency, the likelihood of severe adverse health consequences from its use is considered remote. Detailed information regarding the precise models, specifications, and batch numbers of the implicated sutures can be found within the "Medical Device Recall Event Report Form" attached to the official NMPA announcement. Although no specific inspection dates were provided in the document, the company's voluntary action underscores its responsibility to address quality control issues. This recall, published by the NMPA on July 29, 2019, highlights the regulatory framework's role in public safety and the manufacturer's obligation to ensure the reliability and safety of medical products distributed to healthcare providers and patients. The company's prompt response aims to mitigate any potential risks associated with the faulty sealing and uphold product quality standards.

Company: https://www.globalkeysolutions.net/companies/jiangxi-kangding-biotechnology-co-ltd/d7564266-4394-4eb7-bb89-dc15cb7d8d88/